Search This Blog

Tuesday, November 12, 2019

Reata Pharmaceuticals EPS misses by $0.08, beats on revenue

Reata Pharmaceuticals (NASDAQ:RETA): Q3 GAAP EPS of -$1.32 misses by $0.08.
Revenue of $8.24M (+59.1% Y/Y) beats by $0.81M.
Shares -4.99% PM.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)